10x Genomics and A*STAR GIS Launch TISHUMAP Study to Uncover Novel Cancer and Inflammatory Disease Therapies

Reuters

2025/07/17

<a href="https://laohu8.com/S/TXG">10x Genomics</a> and A*STAR GIS Launch TISHUMAP Study to Uncover Novel Cancer and Inflammatory Disease Therapies

10x Genomics Inc. and the A*STAR Genome Institute of Singapore have announced the launch of the TISHUMAP study, a collaborative research initiative aimed at advancing AI-driven drug target discovery. This study will utilize 10x Genomics' Xenium platform to analyze up to 2,500 formalin-fixed paraffin-embedded (FFPE) clinical tissue samples, focusing on cancers such as gastric, liver, and colorectal. The goal is to uncover novel biomarkers and therapeutic targets for cancer and inflammatory diseases by creating a comprehensive molecular-level map of gene activity within intact tissues. This collaboration is expected to significantly enhance the identification of new diagnostics and potential personalized treatment plans, although specific results from the study have not been presented yet.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. 10x Genomics Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: LA32191) on July 17, 2025, and is solely responsible for the information contained therein.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2552458481"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2552458481\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2552458481?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-07-17 21:01","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2552458481","market":"us","top_or_hot":-1,"title":"10x Genomics and A*STAR GIS Launch TISHUMAP Study to Uncover Novel Cancer and Inflammatory Disease Therapies","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/TXG\">10x Genomics</a> and A*STAR GIS Launch TISHUMAP Study to Uncover Novel Cancer and Inflammatory Disease Therapies\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        10x Genomics Inc. and the A*STAR Genome Institute of Singapore have announced the launch of the TISHUMAP study, a collaborative research initiative aimed at advancing AI-driven drug target discovery. This study will utilize 10x Genomics' Xenium platform to analyze up to 2,500 formalin-fixed paraffin-embedded (FFPE) clinical tissue samples, focusing on cancers such as gastric, liver, and colorectal. The goal is to uncover novel biomarkers and therapeutic targets for cancer and inflammatory diseases by creating a comprehensive molecular-level map of gene activity within intact tissues. This collaboration is expected to significantly enhance the identification of new diagnostics and potential personalized treatment plans, although specific results from the study have not been presented yet.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. 10x Genomics Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: LA32191) on July 17, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>10x Genomics and A*STAR GIS Launch TISHUMAP Study to Uncover Novel Cancer and Inflammatory Disease Therapies</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n10x Genomics and A*STAR GIS Launch TISHUMAP Study to Uncover Novel Cancer and Inflammatory Disease Therapies\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time smaller\">2025-07-17 21:01</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/TXG\">10x Genomics</a> and A*STAR GIS Launch TISHUMAP Study to Uncover Novel Cancer and Inflammatory Disease Therapies\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        10x Genomics Inc. and the A*STAR Genome Institute of Singapore have announced the launch of the TISHUMAP study, a collaborative research initiative aimed at advancing AI-driven drug target discovery. This study will utilize 10x Genomics' Xenium platform to analyze up to 2,500 formalin-fixed paraffin-embedded (FFPE) clinical tissue samples, focusing on cancers such as gastric, liver, and colorectal. The goal is to uncover novel biomarkers and therapeutic targets for cancer and inflammatory diseases by creating a comprehensive molecular-level map of gene activity within intact tissues. This collaboration is expected to significantly enhance the identification of new diagnostics and potential personalized treatment plans, although specific results from the study have not been presented yet.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. 10x Genomics Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: LA32191) on July 17, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4548","symbol_name":"巴美列捷福持倉","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250717:nNDLc0q6H7:1","article_id":"2552458481","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2552458481","pubTimestamp":1752757297,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"10x Genomics Inc. and the A*STAR Genome Institute of Singapore have announced the launch of the TISHUMAP study, a collaborative research initiative aimed at advancing AI-driven drug target discovery. This study will utilize 10x Genomics' Xenium platform to analyze up to 2,500 formalin-fixed paraffin-embedded  clinical tissue samples, focusing on cancers such as gastric, liver, and colorectal. The goal is to uncover novel biomarkers and therapeutic targets for cancer and inflammatory diseases by creating a comprehensive molecular-level map of gene activity within intact tissues. This collaboration is expected to significantly enhance the identification of new diagnostics and potential personalized treatment plans, although specific results from the study have not been presented yet.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for inform","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4548":"巴美列捷福持仓","BK4121":"生命科学工具和服务","LU1861559042.SGD":"日兴方舟颠覆性创新基金B SGD","BK4588":"碎股","TXG":"10x Genomics, Inc.","LU1861558580.USD":"日兴方舟颠覆性创新基金B","BK4585":"ETF&股票定投概念"},"translate_title":"10x Genomics和A*STAR GIS启动TISHUMAP研究，揭示新型癌症和炎症性疾病疗法","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TXG":0.9},"content_text":"10x Genomics and A*STAR GIS Launch TISHUMAP Study to Uncover Novel Cancer and Inflammatory Disease Therapies\n    \n\n        10x Genomics Inc. and the A*STAR Genome Institute of Singapore have announced the launch of the TISHUMAP study, a collaborative research initiative aimed at advancing AI-driven drug target discovery. This study will utilize 10x Genomics' Xenium platform to analyze up to 2,500 formalin-fixed paraffin-embedded (FFPE) clinical tissue samples, focusing on cancers such as gastric, liver, and colorectal. The goal is to uncover novel biomarkers and therapeutic targets for cancer and inflammatory diseases by creating a comprehensive molecular-level map of gene activity within intact tissues. This collaboration is expected to significantly enhance the identification of new diagnostics and potential personalized treatment plans, although specific results from the study have not been presented yet.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. 10x Genomics Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: LA32191) on July 17, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}